Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Chambers

Showing results (401-410 of 520) with videos related to

Pageof 52
Sort By:
The Journal of Infectious Diseases|May 6, 2017
White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet NeedsHelen W Boucher, Paul G Ambrose, H F Chambers, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|October 17, 2007
Osteopontin expression in normal skin and non-melanoma skin tumorsPi-Ling Chang, Louie Harkins, Yu-Hua Hsieh, et al.
Experimental Cell Research|August 1, 1995
Effects of the disintegrin eristostatin on individual steps of hematogenous metastasisV L Morris, E E Schmidt, S Koop, et al.
Journal of Cellular Biochemistry|January 12, 2002
Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequencesShigeyuki Kon, Yasuyuki Yokosaki, Masahiro Maeda, et al.
Cancer Research|April 4, 2002
Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancyGeorge N Naumov, Ian C MacDonald, Pascal M Weinmeister, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1990
Identification of a serum-inducible messenger RNA (5B10) as the mouse homologue of calcyclin: tissue distribution and expression in metastatic, ras-transformed NIH 3T3 cellsX J Guo, A F Chambers, C L Parfett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Serial plasma osteopontin levels have prognostic value in metastatic breast cancerVivien H C Bramwell, Gordon S Doig, Alan B Tuck, et al.
Breast Cancer Research and Treatment|April 26, 2008
Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancerVivien H C Bramwell, Gordon S Doig, Alan B Tuck, et al.
International Journal of Cancer|May 13, 2008
Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1Benjamin D Hedley, Danny R Welch, Alison L Allan, et al.
Clinical & Experimental Metastasis|January 15, 2011
The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasisJason L Townson, Ian C Macdonald, Karen T Liby, et al.
Pageof 52

Showing results (401-410 of 520) with videos related to

Sort By:
Pageof 52
The Journal of Infectious Diseases|May 6, 2017
White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet NeedsHelen W Boucher, Paul G Ambrose, H F Chambers, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|October 17, 2007
Osteopontin expression in normal skin and non-melanoma skin tumorsPi-Ling Chang, Louie Harkins, Yu-Hua Hsieh, et al.
Experimental Cell Research|August 1, 1995
Effects of the disintegrin eristostatin on individual steps of hematogenous metastasisV L Morris, E E Schmidt, S Koop, et al.
Journal of Cellular Biochemistry|January 12, 2002
Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequencesShigeyuki Kon, Yasuyuki Yokosaki, Masahiro Maeda, et al.
Cancer Research|April 4, 2002
Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancyGeorge N Naumov, Ian C MacDonald, Pascal M Weinmeister, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1990
Identification of a serum-inducible messenger RNA (5B10) as the mouse homologue of calcyclin: tissue distribution and expression in metastatic, ras-transformed NIH 3T3 cellsX J Guo, A F Chambers, C L Parfett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Serial plasma osteopontin levels have prognostic value in metastatic breast cancerVivien H C Bramwell, Gordon S Doig, Alan B Tuck, et al.
Breast Cancer Research and Treatment|April 26, 2008
Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancerVivien H C Bramwell, Gordon S Doig, Alan B Tuck, et al.
International Journal of Cancer|May 13, 2008
Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1Benjamin D Hedley, Danny R Welch, Alison L Allan, et al.
Clinical & Experimental Metastasis|January 15, 2011
The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasisJason L Townson, Ian C Macdonald, Karen T Liby, et al.
Pageof 52